Author Archives: Mark Senak

Weekly Roundup 5.4.18

It is apparently May. Hard to believe. It is that time of year when one day you have the furnace on because it is so chilly and the herbs you just planted on the last warm day are threatened with … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 5.4.18

Treating the Patient, Not the Symptoms – FDA and Digital Health

Last week Commissioner Scott Gottlieb delivered remarks at the Health Datapalooza, the meeting representing a nexus between innovation in digital health and the world of policy. He began his talk by saying that for most of the last century, medical … Continue reading

Posted in FDA Image, FDA Policy, Medical Devices | 1 Comment

Weekly Roundup 4.27.18

Another busy week that did not permit me time to get to some of the postings I have been working on between Roundups, but next week look for some. There has certainly been a lot going on and a lot … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 4.27.18

Weekly Roundup 4.20.2018

In some recent postings, it has been noted that the FDA Commissioner has made liberal use of the vehicle of “Commissioner Statements”. Last month, there were 9 – on average 2 a week. Then suddenly this month, the entire first … Continue reading

Posted in Weekly Roundup | Comments Off on Weekly Roundup 4.20.2018

Perspective on Pharma Support for Patient Advocacy Organizations

Last week Kaiser Health News (KHN) released a database called “Pre$cription for Power” that tracked pharmaceutical company donations made to patient advocacy groups, with an extensive accompanying article.  The database is an important collection of information and serves to enhance transparency … Continue reading

Posted in Pharma Industry Image, Politics | 1 Comment